ALLMedicine™ Rabies Center
Research & Reviews 1,671 results
https://doi.org/10.1016/S1473-3099(22)00273-0
The Lancet. Infectious Diseases; Samuels AM, Ansong D et. al.
Jun 27th, 2022 - Controlled infection studies in malaria-naive adults suggest increased vaccine efficacy for fractional-dose versus full-dose regimens of RTS,S/AS01. We report first results of an ongoing trial assessing different fractional-dose regimens in childr...
https://doi.org/10.1016/j.vaccine.2022.06.035
Vaccine Wang L, Zhang J et. al.
Jun 25th, 2022 - To evaluate the safety and immunogenicity of rabies vaccine for human use after post-exposure in China. A systematic search was performed from PubMed, EMBASE, CNKI and Cochrane Library database, supplemented by manual retrieval. According to the i...
https://doi.org/10.1001/jamanetworkopen.2022.16631
JAMA Network Open; Yuan F, Iso T et. al.
Jun 22nd, 2022 - Fatal human rabies infections can be prevented through appropriate rabies postexposure prophylaxis (PEP). Errors in patient selection and administration of human rabies immune globulin in the emergency department (ED) setting were identified in a ...
https://clinicaltrials.gov/ct2/show/NCT04019444
Jun 21st, 2022 - This is a single-center, observer-blinded, Phase 1, dosage-escalation trial to evaluate the safety, tolerability, reactogenicity, and immunogenicity of ChAd155-RG compared with RABAVERT in rabies virus-naïve healthy male and non-pregnant female ad...
https://clinicaltrials.gov/ct2/show/NCT02374814
Jun 13th, 2022 - This is an exploratory vaccine trial to evaluate immunogenicity of a non-licensed dosing schedule and route of administration for a currently FDA licensed rabies vaccine for pre-exposure prophylaxis against rabies infection. The goal of this study...
Guidelines 1 results
https://doi.org/10.1016/j.annemergmed.2010.05.020
Annals of Emergency Medicine;
Jul 22nd, 2010 - Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practice.|2010| ,|immunology,immunology,prevention & control,administration & dosage,adverse ...
Drugs 11 results see all →
Clinicaltrials.gov 117 results
https://clinicaltrials.gov/ct2/show/NCT04019444
Jun 21st, 2022 - This is a single-center, observer-blinded, Phase 1, dosage-escalation trial to evaluate the safety, tolerability, reactogenicity, and immunogenicity of ChAd155-RG compared with RABAVERT in rabies virus-naïve healthy male and non-pregnant female ad...
https://clinicaltrials.gov/ct2/show/NCT02374814
Jun 13th, 2022 - This is an exploratory vaccine trial to evaluate immunogenicity of a non-licensed dosing schedule and route of administration for a currently FDA licensed rabies vaccine for pre-exposure prophylaxis against rabies infection. The goal of this study...
https://clinicaltrials.gov/ct2/show/NCT03965962
May 24th, 2022 - Study duration per participant was approximately 7 months including: 1 day of screening and vaccination, a total of 5 vaccine injections over a 28-day period, 1 safety-follow up visit at Day 42, 1 safety follow-up/end of study visit at Day 56 and ...
https://clinicaltrials.gov/ct2/show/NCT05382650
May 19th, 2022 - BACKGROUND: Rabies PEP consists of thorough wound cleansing, administration of HRIG 20 IU/kg body weight, and 4 to 5 doses of rabies vaccine. The safety of HRIG 300 IU/mL has been confirmed only for adult patients. Although the safety of HRIG 300 ...
https://clinicaltrials.gov/ct2/show/NCT04478084
May 12th, 2022 - The duration of each participant's participation in the study is approximately 7 months (28 day-vaccination period followed by 6 month safety follow-up period).
News 136 results
https://www.medscape.com/viewarticle/976095
Jun 24th, 2022 - LONDON (Reuters) - GSK and Novartis reinforced commitments on Thursday to tackle neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways to better combat illnesses affecting more than a billion people, mos...
https://www.medscape.com/viewarticle/974443
May 27th, 2022 - Healthcare providers should be aware of important updates to vaccine recommendations that could affect patients preparing to travel internationally this summer. This includes information about: New rabies pre-exposure prophylaxis guidelines (PrEP)...
https://www.medscape.com/viewarticle/974298
May 19th, 2022 - Each year, there are about 59,000 deaths from rabies globally. Most of these occur outside the United States and are the result of dog bites. Since infection with rabies is almost always fatal, there has been considerable attention given to vaccin...
https://www.mdedge.com/psychiatry/article/254207/schizophrenia-other-psychotic-disorders/cats-toxoplasmosis-and-psychosis
E. Fuller Torrey, MD
May 2nd, 2022 - It has been clearly established that most human infectious diseases are caused by infectious agents that have been transmitted from animals to humans. 1 Based on published estimates from the 2000s, 60% to 76% of emerging infectious disease events a.
https://www.medscape.com/viewarticle/971878
Apr 11th, 2022 - News of rabid foxes or other animals doesn't make quite as much of a stir here in Western Maryland as it did on Capitol Hill. Here, it seems to be more regarded as a hazard of country living. https://twitter.com/thecapitolfox/status/15114073316612...